These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29056485)
21. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. Salonen J; Laitinen L; Kaukonen AM; Tuura J; Björkqvist M; Heikkilä T; Vähä-Heikkilä K; Hirvonen J; Lehto VP J Control Release; 2005 Nov; 108(2-3):362-74. PubMed ID: 16169628 [TBL] [Abstract][Full Text] [Related]
22. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles. Keohane K; Brennan D; Galvin P; Griffin BT Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950 [TBL] [Abstract][Full Text] [Related]
23. Novel delivery systems for improving the clinical use of peptides. Kovalainen M; Mönkäre J; Riikonen J; Pesonen U; Vlasova M; Salonen J; Lehto VP; Järvinen K; Herzig KH Pharmacol Rev; 2015 Jul; 67(3):541-61. PubMed ID: 26023145 [TBL] [Abstract][Full Text] [Related]
24. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib. Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412 [TBL] [Abstract][Full Text] [Related]
25. Oral Curcumin via Hydrophobic Porous Silicon Carrier: Preparation, Characterization, and Toxicological Evaluation In Vivo. Zhang Y; Li W; Liu D; Ge Y; Zhao M; Zhu X; Li W; Wang L; Zheng T; Li J ACS Appl Mater Interfaces; 2019 Sep; 11(35):31661-31670. PubMed ID: 31430116 [TBL] [Abstract][Full Text] [Related]
36. Surface modified porous silicon with chitosan coating as a pH-responsive controlled delivery system for lutein. Li W; Liu D; Song L; Li H; Dai S; Su Y; Li Q; Li J; Zheng T Food Funct; 2022 Jun; 13(11):6129-6138. PubMed ID: 35579219 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues. Tzur-Balter A; Shatsberg Z; Beckerman M; Segal E; Artzi N Nat Commun; 2015 Feb; 6():6208. PubMed ID: 25670235 [TBL] [Abstract][Full Text] [Related]
38. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release. Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206 [TBL] [Abstract][Full Text] [Related]
39. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release. Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268 [TBL] [Abstract][Full Text] [Related]
40. Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles. Obaidat RM; Tashtoush BM; Bayan MF; Al Bustami RT; Alnaief M AAPS PharmSciTech; 2015 Dec; 16(6):1235-44. PubMed ID: 25761387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]